ARCHIVES

Top Officials Resign From San Antonio’s Institute for Drug Development.

This article is from The Cancer Letter archive.

Vol. 33 No. 03 | January 26, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Congress Working On Interim Financing Measure to Fund Agencies, Including NCI, Through Election

September 26, 1980

Flavopiridol Plus Cisplatin Tested In Phase II Trial

October 26, 2007

Ratain To Lead New Center For Personalized Therapeutics At University of Chicago. Report Calls For Better Risk Stratification And New Name For DCIS.

January 22, 2010

Clinical Practice Guidelines Don’t Meet IOM Standards

June 26, 2013

NCI Cancer Studies In China Intact; Visits Delayed

July 14, 1989

Committee Recommends FDA Approval Of Three New Drugs For Cancer Treatment

March 27, 1998